An Adaptive Dose Escalation and Expansion Basket Trial to Explore the Safety, Pharmacology, and Clinical Activity of TGD001 in Immune-Mediated Thrombotic Thrombocytopenic Purpura (iTTP) and Other Thrombotic Microangiopathies
Latest Information Update: 16 Mar 2026
At a glance
- Drugs Microlyse (Primary)
- Indications Thrombotic microangiopathies; Thrombotic thrombocytopenic purpura
- Focus Adverse reactions
- Sponsors TargED Biopharmaceuticals
Most Recent Events
- 16 Mar 2026 New trial record